Oceanside, CA - March 18, 2026 - PRESSADVANTAGE - Moment of Clarity has released a new educational resource examining ...

Understanding what depression is – and what it is not – is often the first step toward relief.

GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness ...

A landmark paper published in Lancet Psychiatry—the largest-ever review of the safety and efficacy of cannabinoids across a ...

The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder. Rejoyn, made by Otsuka Pharmaceutical and Click Therapeutics, ...

Depression-related fatigue is caused by cellular "overworking" at rest and a failure to produce energy under stress.

Researchers found that the cells of young adults with depression overproduce energy while resting but struggle to respond to ...

There’s ‘no evidence’ marijuana works to treat most mental health disorders, largest review of its kind finds - More than 52 ...

Additionally, some patients report distressing withdrawal symptoms when they try to stop, such as insomnia, anxiety, and ...

People frequently use medical cannabis to treat anxiety, depression and PTSD, but two new reviews show there is little ...

People with psoriasis prescribed bimekizumab have no greater risk for major depressive disorder or suicidal ideation than ...

Researchers have suggested it may not be effective in treating some of the most common conditions it’s prescribed for.